News Sentiment

DCTH sentiment intelligence

Delcath Systems Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 58 Balanced news tone 66 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 13.01 Week of 10 Jul 2026
Weighted tone 58/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

77/100 classification confidence.

Company focus 54

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend active

-1.4% over one week, +11.0% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

Understanding Momentum Shifts in (DCTH)

Market Reaction

Balanced read

67/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 77/100 classification
One-week reaction -1.4% Price digesting
Trend fit Trend active 11.0% over four weeks
Fair value 43.1% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 23
Neutral 39
Negative 4

Relevance

Why the article matched

Direct first
Direct company coverage 54
Industry context 12
Sector context 0

Sources

Coverage mix

Publishers
Market source 18
TradingView 8
TradingKey 7
Stock Titan 5
Stock Traders Daily 3
GuruFocus 2
StockStory 2
dars.gov.et 1

Event Lens

What the news is about

Classified themes
Market update 31
Earnings 25
Analyst action 4
Regulatory and legal 3
Guidance 2
Capital return 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 66
Stock Traders Daily Direct company coverage

Understanding Momentum Shifts in (DCTH)

Delcath Systems Inc. (NASDAQ: DCTH) is showing neutral near-term sentiment with strong mid-term sentiment potentially stalling. The analysis identifies no clear price positioning signal but notes compelling upside potential as no resistance levels remain above the current price.

Tone
Neutral 50/100
Event
Market update
Published
11 Jul 2026 22:44
Source
Stock Traders Daily
grafa.com Direct company coverage

Delcath Systems begins Phase 2 breast cancer trial

Delcath Systems has dosed the first patient in a Phase 2 trial for its HEPZATO treatment, targeting liver-dominant HER2-negative metastatic breast cancer patients who have failed prior treatments. The trial aims to enroll approximately 90 patients across more than 20 global sites

Tone
Positive 72/100
Event
Market update
Published
09 Jul 2026 12:25
Source
grafa.com
Market source Direct company coverage

Delcath Systems Announces First Patient Dosed in Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Breast Cancer

Delcath Systems announced that the first patient has been dosed in its global Phase 2 clinical trial (DELUMA) evaluating HEPZATO in combination with standard of care for liver-dominant metastatic breast cancer. This randomized, controlled trial will enroll approximately 90 patien

Tone
Positive 70/100
Event
Market update
Published
09 Jul 2026 12:13
Source
Market source
Investing.com Direct company coverage

Delcath doses first patient in breast cancer trial in Milan

Delcath Systems Inc. has dosed the first patient in its Phase 2 clinical trial (DELUMA) in Milan, Italy, evaluating HEPZATO combined with standard of care for liver-dominant metastatic breast cancer. This trial aims to assess the safety and efficacy of HEPZATO in HER2-negative pa

Tone
Positive 70/100
Event
Market update
Published
09 Jul 2026 12:13
Source
Investing.com
TradingView Direct company coverage

Price to sales forward of Delcath Systems, Inc. – NASDAQ:DCTH

This article provides the "Price to sales forward" metric for Delcath Systems, Inc. (NASDAQ: DCTH) on TradingView. It appears to be a financial data snippet rather than an in-depth analysis, focusing solely on this specific financial ratio for the company. The page also includes

Tone
Neutral 50/100
Event
Market update
Published
01 Jul 2026 23:10
Source
TradingView
Stock Traders Daily Direct company coverage

Avoiding Lag: Real-Time Signals in (DCTH) Movement

This article provides a real-time signal analysis for Delcath Systems Inc. (DCTH), highlighting strong near and mid-term sentiment and compelling upside potential due to an absence of resistance above the current price. It outlines institutional trading strategies including posit

Tone
Positive 72/100
Event
Market update
Published
30 Jun 2026 21:40
Source
Stock Traders Daily
marketscreener.com Direct company coverage

Delcath Systems, Inc.(NasdaqCM:DCTH) added to Russell Small Cap Comp Value Benchmark

Delcath Systems, Inc. (NasdaqCM:DCTH) has been added to the Russell Small Cap Comp Value Benchmark. This inclusion is a significant development for the interventional oncology company, whose proprietary products focus on treating primary and metastatic liver cancers. The announce

Tone
Positive 72/100
Event
Market update
Published
29 Jun 2026 11:10
Source
marketscreener.com
TradingView Direct company coverage

Price to book forward of Delcath Systems, Inc. – SWB:DV3R

This article displays the "Price to book forward" financial metric for Delcath Systems, Inc. (SWB:DV3R) on the Stuttgart Stock Exchange. It indicates that the market was closed with no trades at the time of the report. The content provides a basic financial overview for this spec

Tone
Neutral 50/100
Event
Market update
Published
29 Jun 2026 07:09
Source
TradingView
TradingView Direct company coverage

Price to earnings forward of Delcath Systems, Inc. – NASDAQ:DCTH

This article provides financial information for Delcath Systems, Inc. (NASDAQ: DCTH), specifically focusing on its forward price-to-earnings ratio. It displays a "Period," "Value," "Change," and "Change %" table, indicating that the data was made by humans. The content is essenti

Tone
Neutral 50/100
Event
Earnings
Published
29 Jun 2026 01:09
Source
TradingView
www.marketscreener.com Direct company coverage

Delcath Systems, Inc.(NasdaqCM: DCTH) added to Russell 3000 Value Benchmark

Delcath Systems, Inc. (NasdaqCM: DCTH), an interventional oncology company specializing in liver cancer treatments, has been added to the Russell 3000 Value Benchmark. This inclusion follows several other recent additions to various Russell indices, including the Russell Microcap

Tone
Positive 71/100
Event
Market update
Published
28 Jun 2026 11:10
Source
www.marketscreener.com
TradingView Direct company coverage

Delcath Systems, Inc. Actuals & Estimates (FWB:DV3R)

This article provides financial actuals and estimates for Delcath Systems, Inc. (FWB:DV3R), offering insights into its income statement, balance sheet, cash flow, and valuation metrics. It includes analyst forecasts, historical price data, upcoming earnings dates, and details on

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 19:40
Source
TradingView
TradingView Direct company coverage

Delcath Systems, Inc. Actuals & Estimates (NASDAQ:DCTH)

This article provides an overview of Delcath Systems, Inc. (NASDAQ:DCTH), including its current stock price, historical performance, and analyst forecasts. It details financial actuals and estimates, earnings per share, revenue, net income, and its market capitalization, and also

Tone
Positive 67/100
Event
Earnings
Published
26 Jun 2026 08:40
Source
TradingView
TradingView Direct company coverage

DCTH Forecast — Price Target — Prediction for 2027

Delcath Systems, Inc. (DCTH) currently trades at $12.32, with analysts providing a 1-year price target ranging from $16.00 to $30.00. The company's stock has seen a 1.90% increase over the past week and a 10.99% rise over the last month, despite a -11.37% decrease over the last y

Tone
Positive 64/100
Event
Guidance
Published
26 Jun 2026 08:12
Source
TradingView
TradingView Direct company coverage

Delcath Systems, Inc. Actuals & Estimates (LS:A2PT5P)

This article provides an overview of Delcath Systems, Inc. (A2PT5P) stock, including current price, analyst forecasts, market capitalization, and financial performance. It highlights key financial metrics, past earnings, and upcoming earnings dates, along with offering guidance o

Tone
Positive 61/100
Event
Earnings
Published
26 Jun 2026 05:40
Source
TradingView
TradingKey Direct company coverage

Delcath Systems Inc (DCTH) Institutional Confidence

Delcath Systems Inc (DCTH) has an institutional shareholding score of 3.00, placing it 132nd out of 203 in the Healthcare Equipment & Supplies industry. The institutional shareholding proportion decreased by 20.44% quarter-over-quarter to 49.40%, with Bill Nygren | OAKMX being th

Tone
Negative 38/100
Event
Market update
Published
18 Jun 2026 18:39
Source
TradingKey
TradingKey Direct company coverage

Delcath Systems Inc (DCTH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for Delcath Systems Inc (DCTH), focusing on its business segments. As of the latest update on April 6, the company's revenue is primarily driven by HEPZATO KIT, accounting for 92.50% of revenue with $78.83 million, while CHEMOSAT contribu

Tone
Neutral 50/100
Event
Earnings
Published
18 Jun 2026 18:09
Source
TradingKey
TradingKey Direct company coverage

Delcath Systems Inc (DCTH) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Delcath Systems Inc (DCTH), detailing its current price momentum score, support and resistance levels, and various technical indicator and moving average signals. Currently, the stock's price momentum score is 9.38, suggesting a range

Tone
Positive 62/100
Event
Market update
Published
18 Jun 2026 11:10
Source
TradingKey
TradingKey Direct company coverage

Delcath Systems Inc (DCTH) Valuation: PE, PB & Fair Value Analysis

Delcath Systems Inc (DCTH) has a current valuation score of 4.97, placing it low within the Healthcare Equipment & Supplies industry. Its P/E ratio stands at 805.54, which is at its recent high and significantly above its recent low. However, relevant data for P/B, P/S, and P/CF

Tone
Negative 38/100
Event
Market update
Published
18 Jun 2026 11:10
Source
TradingKey
TradingKey Direct company coverage

Delcath Systems Inc (DCTH) Dividends & Stock Splits: Historical Payouts and Event Timeline

The article provides a detailed look into Delcath Systems Inc (DCTH)'s dividend and stock split history. It states that the company has distributed no dividends in the past five years and has no record of stock splits. The page also displays current market data for DCTH, includin

Tone
Neutral 50/100
Event
Capital return
Published
18 Jun 2026 10:10
Source
TradingKey
TradingKey Direct company coverage

Delcath Systems Inc (DCTH) Earnings Forecast: Future EPS & Revenue Growth Estimates

Delcath Systems Inc (DCTH) has an earnings forecast score of 8.57, ranking 26th in the Healthcare Equipment & Supplies industry, with an average price target of $22.00. Based on 6 analysts, the stock has a "Buy" rating with a target price of $22.333, representing an upside of 89.

Tone
Positive 76/100
Event
Earnings
Published
17 Jun 2026 17:40
Source
TradingKey